Uncategorised - European Medical Journal

Tralokinumab – Updates in Atopic Dermatitis

Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin condition, associated with a high disease burden that affects patients…

Fosfomycin Offers Alternative for Drug-Resistant Prostatitis

Fosfomycin may offer a viable treatment alternative for bacterial prostatitis, particularly in patients with multidrug-resistant infections, according to a new systematic review.

Are Spondyloarthritis Diagnostic Criteria Failing Latin America?

Spondyloarthritis (SpA) classification criteria show variable diagnostic performance in Latin American populations, according to a newly published systematic review and meta-analysis.

Can Eye Drops Heal Scars? Timolol Tested After Mammoplasty

A randomized controlled trial reveals that topical timolol may offer an effective and non-invasive solution to improve the appearance of immature scars following mammoplasty surgery.

New Prostate Cancer Risk Gene Identified

The investigation began with a comparison between 3,716 PCa patients from Johns Hopkins University, Baltimore, Maryland.

The word spotlight on a blue background

Spotlight: May 2025

Catch up on May’s key pharma news, research updates and policy shifts.

Innovator, Author, and Leader: Interview with Srihari S. Naidu

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions as a published…

DBT Outperforms Mammography for Breast Cancer Screening in High-Risk Women

Study shows DBT improves breast cancer screening outcomes in high-risk women, particularly those with dense breast tissue.

Experimental Drug Shows Hopeful Results in Aggressive ALS

Experimental drug jacifusen shows promise for rare ALS, with some patients experiencing unprecedented recovery and stabilisation.

Bradley Monk

Onc Now: Episode 18: What's New from ESGO 2025?

Bradley Monk, Medical Director of Late-Phase Research at Florida Cancer Specialists, shares his insights from ESGO 2025 and landmark studies in gynaecologic oncology.